Related Experiment Video
Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Recent and anticipated novel drug approvals (4Q 2025 through 3Q 2026)
Brittany L Karas1, Mary Golf1, Elizabeth Shepard1
1Northwestern Medicine, Chicago, IL, USA.
Health-system pharmacists can prepare for upcoming novel drug approvals, focusing on therapies for rare diseases and cancer. This review highlights key drugs expected to impact hospital and clinic care within the next year.
Area of Science:
- * Pharmaceutical Science
- * Clinical Pharmacy
- * Health-System Pharmacy
Background:
- * Health-system pharmacists are vital for managing formularies and resources.
- * Monitoring the pharmaceutical pipeline is essential for optimizing new therapy integration.
- * Proactive updates support pharmacists in resource allocation and clinical program development.
Purpose of the Study:
- * To provide health-system pharmacists with updates on novel drug approvals.
- * To identify anticipated drug approvals with significant clinical and financial impact.
- * To support strategic planning for new therapies in hospital and clinic settings.
Main Methods:
- * Review of novel drugs awaiting US Food and Drug Administration approval.
- * Analysis focused on the 12-month period from Q4 2025 to Q3 2026.
- * Selection of drugs with anticipated significant clinical and financial impact.
Main Results:
- * 41 novel drugs are awaiting US Food and Drug Administration approval.
- * The pipeline includes therapies for rare diseases such as Wiskott-Aldrich syndrome and mucopolysaccharidosis type II.
- * Targeted cancer treatments and cell and gene therapies are prominent in the pipeline.
Conclusions:
- * Novel therapies are continuously enhancing the drug development pipeline.
- * Upcoming approvals are expected to significantly influence various disease state treatments.
- * Pharmacists are key to navigating the integration of these advanced therapies.
More Related Videos
09:55Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Clinical Trials: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Regulation
Drug Products: Biologics, Biosimilars and Interchangeables
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...